SIGA Technologies Inc. Common Stock (SIGA)
StalwartFairStock Score: 52/100 — MIXED
Key Financials
| Current Price | $4.17 |
| Market Cap | $322M |
| P/E Ratio | 14.89 |
| ROE | 11% |
| Dividend Yield | —% |
| Sector | Healthcare |
Strengths
- Generates $29 million in annual free cash flow (9.0% yield on market cap)
- Solid return on equity of 11.2% above cost of capital
- Conservative balance sheet with debt-to-equity of just 0.00, providing financial flexibility
- Altman Z-Score of 10.0 confirms minimal bankruptcy risk and strong solvency
Concerns
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Revenue declining at 95.3% year-over-year signals potential demand weakness or market share loss
AI Analysis
SIGA Technologies Inc. Common Stock is a micro-cap healthcare company valued at $322 million. Revenue stands at $95 million, though the company is currently unprofitable. From a quality standpoint, SIGA shows Altman Z-Score of 10.0 confirms fortress-level solvency and adequate 11% ROE. On valuation, the stock is attractively valued at 14.2x earnings, with trades above its Graham Number with a negative 1% margin. Growth dynamics show revenue growing at -95.3% and profit growth of -111.9%. Our composite FairStock Score of 52/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $29 million in annual free cash flow (9.0% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer